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or controversial. Obesity appears to increase the risk of pan-
creatic cancer in the West but not in Japan. Diets high in pro-
cessed or red meat, diets low in fruits and vegetables, phy-
tochemicals such as lycopene and flavonols, have been pro-
posed and refuted as risk or protective factors in different 
trials. The best established and single most important risk 
factor for cancer as well as pancreatitis and the one to clear-
ly avoid is tobacco smoke.  Copyright © 2011 S. Karger AG, Basel 
 Chronic Pancreatitis 
 The only established risk factor for the development of 
chronic pancreatitis was, for a long time, the immoderate 
use of alcohol, frequently in combination with a poor so-
cioeconomic status, because several epidemiologic stud-
ies had identified alcohol consumption to be associated 
with chronic pancreatitis. Since less than 10% of heavy 
drinkers develop chronic pancreatitis and, on the other 
hand, teetotalers also develop pancreatitis, other risk fac-
tors have to exist. While risk factors only imply a statisti-
cal association they may also point towards an underly-
ing mechanism of the disease. In the last two decades 
much progress has been made in understanding the biol-
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 Abstract 
 Chronic pancreatitis has long been thought to be mainly as-
sociated with immoderate alcohol consumption. The obser-
vation that only   10% of heavy drinkers develop chronic 
pancreatitis not only suggests that other environmental fac-
tors, such as tobacco smoke, are potent additional risk fac-
tors, but also that the genetic component of pancreatitis is 
more common than previously presumed. Either disease-
causing or protective traits have been indentified for muta-
tions  in  different  trypsinogen  genes,  the gene for the tryp-
sin inhibitor SPINK1, chymotrypsinogen C, and the cystic fi-
brosis transmembane conductance regulator (CFTR). Other 
factors that have been proposed to contribute to pancreati-
tis are obesity, diets high in animal protein and fat, as well as 
antioxidant deficiencies. For the development of pancreatic 
cancer, preexisting chronic pancreatitis, more prominently 
hereditary pancreatitis, is a risk factor. The data on environ-
mental risk factors for pancreatic cancer are, with the nota-
ble exception of tobacco smoke, either sparse, unconfirmed 
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ogy of acute and chronic pancreatitis. We have learned 
that the serine protease trypsin plays a central role in pan-
creatitis  [1, 2] and that pancreatic fibrosis, not unlike liv-
er cirrhosis, represents an impaired balance between con-
nective tissue synthesis and degradation with a patho-
logical shift towards the former  [3] . Exogenous factors 
that regulate these processes are manifold and discussed 
below.
 Nutritional Factors 
 Obesity has been shown in several studies to be associ-
ated with a higher mortality and greater complication 
rate in patients with acute pancreatitis  [4–7] . In a pro-
spective study investigating additional risk factors for al-
cohol-induced chronic pancreatitis, 54% of patients were 
overweight (15.0% obese) before the onset of the disease 
but only 37.7% (3.1% obese) in controls. This suggests that 
obesity and being overweight are additional risk factors 
for developing alcohol-induced chronic pancreatitis  [8] . 
Older studies, however, showed conflicting results about 
the impact of obesity and being overweight on the pro-
gression of alcohol-induced chronic pancreatitis, but few, 
if any of the older studies investigated whether differ-
ences in weight existed before the disease onset  [8–10] . 
Diets high in fat and protein appeared to facilitate the 
progression of chronic pancreatitis, but evidence that 
overnutrition is an initiating factor for the disease is less 
convincing.
 Especially for tropical pancreatitis, malnutrition was 
long believed to be a risk factor. In a prospective case-
control trial by Midha et al.  [11] , malnutrition was inves-
tigated in the context of chronic pancreatitis in India. The 
authors focused on patients with idiopathic pancreatitis 
(i.e. those who do not consume alcohol) and found that 
malnutrition is the result of chronic pancreatitis and its 
progression, rather than a risk factor for the disease onset. 
Similar findings were made by earlier but smaller studies. 
Uscanga et al.  [12] found no relationship between malnu-
trition and idiopathic or alcohol-induced chronic pan-
creatitis at the time of disease manifestation. On the oth-
er hand, all studies showed a significant increase in mal-
nutrition after the onset of the disease, indicating that 
malnutrition is either the result of maldigestion due to 
reduced pancreatic enzymes synthesis or the result of in-
sufficient dietary intake due to pain or other disease com-
plications in patients with chronic pancreatitis. Neither 
of these studies provided evidence that malnutrition can 
actually induce chronic pancreatitis.
 No report has conclusively shown a direct association 
between distinct diets and a risk for developing chronic 
pancreatitis, although the consumption of cassava has 
been implicated in the onset of tropical pancreatitis be-
fore its association with mutations in the SPINK1 gene 
were known and cassava as a risk factor was ruled out in 
case-control studies. Much more is presently known 
about genetic risk factors. The most important ones are 
mutations in the cationic trypsinogen gene  [2, 13–15] 
which were the first identified cause of hereditary pan-
creatitis. In contrast to mutations in the cationic trypsin 
gene, a G191R mutation in the anionic trypsin gene 
(PRSS2) was shown to have a protective effect  [16] . Other 
genetic changes that predispose to pancreatitis were 
found in the trypsin inhibitor gene SPINK1  [16–18] as 
well as in the cystic fibrosis transmembrane regulator 
CFTR (cystic fibrosis transmembane conductance regu-
lator) gene  [19–25] . Because lysosomal cathepsins are a 
known activator of the digestive protease cascade in the 
pancreas  [26] it has been proposed that cathepsin B muta-
tions may represent a genetic risk factor for pancreatitis 
 [27] . In Caucasian patients such an association has, how-
ever, yet to be confirmed  [28] .
 Environmental Toxins 
 The best-established risk factor for chronic pancreati-
tis is alcohol. Excessive alcohol consumption has long 
been known to be associated with chronic pancreatitis 
and this fact has been confirmed in various epidemio-
logic studies  [29–33] . However, since only less than 10% 
of chronic alcoholics develop chronic pancreatitis, addi-
tional risk factors are likely to exist. One of these is to-
bacco smoke as a well-established independent risk factor 
for chronic pancreatitis as well as for pancreatic cancer 
 [34–36] . Since many high alcohol consumers also smoke 
it has long been difficult to distinguish between the two 
toxic exposures. Only recent studies have made that dis-
tinction and have determined that the impact of tobacco 
smoke on the onset of chronic pancreatitis is at least as 
great, if not greater, than that of immoderate alcohol con-
sumption  [35] . No single genetic alteration has been iden-
tified that would determine whether a smoker or drinker 
develops pancreatitis. However, the factors associated 
with idiopathic and tropical pancreatitis such as SPINK1 
mutations, seem to somewhat contribute also to alcohol-
induced pancreatitis  [37] .
 Protective Factors 
 In several studies antioxidants have been proposed to 
have a protective role in pancreatitis. Various antioxi-
dants have been used to treat acute pancreatitis without 
much success and were also discussed as a preventive 
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measure for chronic pancreatitis. Several controlled trials 
investigating the effect of antioxidants on the course of 
chronic pancreatitis have been reported. They showed a 
significant reduction in pain in the antioxidant-treated 
cohort  [38–40] . However, these trials cannot convincing-
ly show a protective role of antioxidants in the develop-
ment of chronic pancreatitis but indicate that treatment 
with antioxidants can reduce the number of pancreatitis 
episodes and pain in individuals already suffering from 
chronic pancreatitis.
 A recent systematic review of the 22 available placebo-
controlled studies, including those using allopurinol and 
N-acetylcysteine, could not demonstrate a general benefit 
of antioxidant treatment on the course of acute pancre-
atitis, post-ERCP pancreatitis or chronic pancreatitis  [41] .
 In an Italian case-control study published in 2005 that 
serum selenium levels were lower in patients with chron-
ic pancreatitis, especially in patients with pancreatic in-
sufficiency. While this correlation indicates selenium de-
ficiency in chronic pancreatitis patients, it should not be 
regarded as proof that low selenium was the cause of the 
disease  [32, 42–44] .
 In clinical trials using antioxidants for treatment of 
chronic pancreatitis, most formulations also contained vi-
tamin E. A study investigating the progression of fibrosis 
in a rat model of chronic pancreatitis could demonstrate 
that vitamin E reduces oxidative stress and collagen depo-
sition  [45] . Human clinical trials or epidemiologic studies 
on the effect of vitamin E in the development or progres-
sion of chronic pancreatitis are currently not available.
 Many different fruits and vegetables including grape 
seeds are rich in phytochemicals with antioxidant prop-
erties. In in vitro studies as well as in one clinical trial, 
grape seed proanthocyanidin extract was found to im-
prove chronic pancreatitis  [46] . A confirmatory would 
still be needed before grape seed extracts could become a 
therapeutic option for chronic pancreatitis. A similarly 
low level of evidence exists for green tea and green tea ex-
tracts. Animal models show a protective effect of green 
tea polyphenols and aqueous extracts from green and 
black tea  [47, 48] , but no convincing clinical trial or epi-
demiologic data supporting this effect in humans are 
currently available.
 Pancreatic Cancer 
 Pancreatic cancer is often diagnosed at an advanced 
stage and even when diagnosed early it has a worse prog-
nosis than almost any other cancer. This is mainly be-
cause of the poor response of pancreatic ductal adenocar-
cinoma to chemotherapy and radiation. Pancreatic can-
cer prevention may therefore become a more promising 
strategy. As for many other cancer types, advanced age is 
a risk factor for pancreatic cancer and the disease is virtu-
ally unknown in children and young adults. Many risk 
factors have been proposed to be associated with pancre-
atic cancer, but only for very few does reliable evidence 
exist that they indeed contribute to an enhanced cancer 
risk.
 Chronic Pancreatitis 
 Chronic pancreatitis is generally regarded as a risk fac-
tor for developing pancreatic cancer and estimates range 
from between 2 and 16% in case-control studies regard-
ing the increase in pancreatic cancer risk in patients with 
chronic pancreatitis. Population-based studies generally 
indicate a much lower ( ! 1%) risk of pancreatic cancer in 
chronic pancreatitis patients than case-control studies. 
The greatest risk for pancreatic cancer is found among 
patients with hereditary pancreatitis (40–70% lifetime 
risk) rather than sporadic pancreatitis, particularly when 
affected patients smoke  [34] . While alcohol is a risk factor 
for chronic pancreatitis and chronic pancreatitis, it is in 
turn also a risk factor for pancreatic cancer which does 
not translate into a direct association between alcohol 
and pancreatic cancer  [33, 49] .
 Overweight and Obesity 
 Being overweight in Western countries seems to be a 
risk factor for pancreatic cancer development  [50–53] , but 
no association between obesity and pancreatic cancer 
could be demonstrated in Japan  [54] . New onset diabetes 
is a suggested risk factor of pancreatic cancer, or is at least 
associated with pancreatic cancer. However, it is not clear 
whether diabetes predisposes to pancreatic cancer or rep-
resents an early manifestation of pancreatic cancer  [55] .
 Other evidence that glucose tolerance and insulin re-
sistance might be a risk factor for pancreatic cancer comes 
from an Italian cohort study. In this study an increased 
use of table sugar was associated with an increased risk 
for pancreatic cancer. The authors suggest that this in-
creased risk is mediated through insulin resistance  [56] . 
Also the intake of more than two soft drinks (sweetened 
soda) per week is associated with a 2-fold increase in pan-
creatic cancer risk  [57] . On the other hand, other studies 
have shown an inverse correlation between sugar con-
sumption and pancreatic cancer  [58] . It needs to be con-
sidered that the latter study did not discriminate between 
table sugar and sweet fresh fruit or other sources of sugar. 
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Thus the protective effect might be due to protective 
compounds in fruit other than fructose and does not 
need to be directly linked to the sugar consumption.
 Three independent studies from 1998 to 2003 showed 
a small but significant increase in pancreatic cancer risk 
in  Helicobacter pylori -positive individuals  [59–61] . More 
recent studies from Sweden and the USA could not con-
firm this correlation  [62, 63] . Thus a possible effect of
 H. pylori infection on the risk to develop pancreatic can-
cer is still unclear.
 Tooth loss and periodontal diseases have been associ-
ated with a variety of cancers. For pancreatic cancer a 
1.5- to 1.7-fold increased risk was seen in individuals with 
a history of periodontal disease or tooth loss of between 
1 and 10 teeth  [64–66] . The underlying mechanisms have 
not been investigated yet. The authors suggest that peri-
odontal disease and tooth loss might be a marker for a 
susceptible immune system.
 Environmental Toxins 
 Only few risk factors for pancreatic cancer have been 
well established. The one with the best evidence is tobac-
co smoke. Current smokers have a 2- to 3-fold increased 
risk of developing pancreatic cancer compared to non-
smokers  [67, 68] . The risk of pancreatic cancer seems to 
increase according to the duration and the amount of 
smoking.
 A study investigating two US cohorts with nearly 2 
million participants could not find any correlation be-
tween coffee consumption or alcohol intake and pancre-
atic cancer  [69] . Also a recent meta-analysis could not 
find a correlation between moderate alcohol drinking 
and pancreatic cancer  [33] .
 Nutritional Risk Factors 
 Dietary factors have been discussed for years as risk or 
protective factors for pancreatic cancer. Several recent ep-
idemiologic studies found a correlation between dietary 
habits and pancreatic cancer.
 A case-control study from Italy reported a positive as-
sociation between high animal protein intake and pan-
creatic cancer but a negative correlation for diets high in 
sugar (mainly from fruits)  [58] . A similar Canadian case-
control study showed a 49% risk reduction for males con-
suming high amounts of fruits and vegetables. However, 
no association was seen in this study between pancreatic 
cancer and alcohol or a Western diet (high in fat, pro-
cessed meat, sweets and desserts)  [70] . A multiethnic co-
hort study has investigated this dietary pattern more 
closely. They found a 50% increased risk for high intake 
of red meat, and a 70% increased risk for high consump-
tion of processed meat, but no association for fat and sat-
urated fat  [71] .
 Mainly case-control studies reported a reduced cancer 
risk associated with diets high in fruits and vegetables. 
However, cohort studies could often not reproduce these 
findings.
 In an Italian cohort study, frequent meat consumption 
doubled the risk for pancreatic cancer  [56] . A cohort 
study from the Netherlands, on the other hand, could not 
show any correlation between the intake of fresh meat, 
other types of meat, fish, eggs, total fat intake or different 
types of fat and risk of pancreatic cancer  [72] . Another 
European prospective cohort study including 520,000 in-
dividuals and 555 pancreatic cancer cases  [73] also found 
no association between nutritional habits and pancreatic 
cancer. A cohort study investigated the effect of diets with 
high glycemic index, a high glycemic load or the total car-
bohydrate intake. Also in this study involving 482,362 
participants and 1,151 pancreatic cancer cases, no con-
vincing association between diet and pancreatic cancer 
was found. The authors postulated a possible association 
between pancreatic cancer and a high intake of free fruc-
tose  [74] . A similar association was found by a group who 
identified a 2-fold increased risk of pancreatic cancer in 
persons consuming more than two soft drinks (sweet-
ened soda) per week  [57] . However, these data were, again, 
not confirmed by other groups, and a meta-analysis of 
four available studies showed no contribution of soft 
drinks to pancreatic cancer development  [75] . Taken to-
gether, the available data do not allow to make definite 
dietary recommendations regarding a reduction in pan-
creatic cancer risk.
 Protective Factors 
 Green tea polyphenols have been shown to inhibit tu-
mor growth in animal models and in in vitro studies. Lin 
et al.  [76] examined the relationship between green tea 
consumption and the risk of death from pancreatic can-
cer in humans and found no significant risk reduction in 
mortality with increasing intake of green tea.
 These data were confirmed by another population-
based cohort study from Japan which followed 101,137 
subjects for 11 years and found no correlation between 
pancreatic cancer and green tea consumption  [77] . There-
fore the protective effect of green tea postulated in cell 
culture models could not be confirmed in epidemiologic 
human studies.
 Citrus Fruits. In 1986 a case-control study suggested a 
reduced risk of pancreatic cancer for individuals with a 
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high intake of citrus fruits (daily consumption)  [78] . 
Studies investigating compounds from Mexican lime re-
cently showed that flavonoids and limoids extracted from 
lime can inhibit pancreatic cancer cell proliferation  [79] . 
A systematic review published in 2009 summarized the 
available studies. The authors found an inverse associa-
tion between intake of citrus fruits and the risk of pan-
creatic cancer, but there was a large variation across stud-
ies and only the case-control studies showed significant 
effects  [80] .
 Phytochemicals. Since many claims were made that 
fruits and vegetables might protect against pancreatic 
cancer, studies were conducted to investigate some more 
well-defined phytocemicals. One candidate was lyco-
pene, a carotenoid with high concentrations in tomatoes. 
A Canadian study found a significant (31%) decrease in 
pancreatic cancer risk for individuals with high intake of 
lycopene, and a lower but still significant risk reduction 
for   -carotene and total carotenoids  [81] was reported. 
 Flavonols have also been shown to have anticancer effects 
in pancreatic cancer models  [82, 83] , but the epidemio-
logic data have shown only a weak association. A US-
based as well as a Finnish study found no significant as-
sociation between flavonol intake and pancreatic cancer 
in an overall analysis, but both studies could show a sig-
nificant risk reduction for the subpopulation of male 
smokers. In the Finnish study, individuals consuming 
supplemental   -tocopherol and/or   -carotene had been 
excluded  [84–86] .
 Vitamins. Vitamins have often been claimed to de-
crease the risk for various cancers. A review of three large 
cohort studies from Harvard Medical School showed that 
higher vitamin D intake was associated with a lower pan-
creatic cancer risk in men and women  [87] . In contrast to 
this, a second case-control study found no association be-
tween low vitamin D levels and pancreatic cancer, but a 
2-fold increased risk in individuals with high 25-hy-
droxyvitamin D  [88] . While investigating the effect of 
genetic variations in antioxidant genes, Tang et al.  [89] 
found a significant reduction of pancreatic cancer risk for 
high vitamin E intake and an increased risk for low vita-
min E intake in individuals with the superoxide dis-
mutase-2 1221G 1 A AA genotype, indicating that defined 
genetic predispositions can interact with environmental 
factors in determining an individual’s pancreatic cancer 
risk.  Folate intake has also been claimed to reduce cancer 
risk. A Swedish cohort study found a tendency towards 
risk reduction for high folate intake from food sources 
but not for folic acid supplementation  [90] . A second co-
hort study could not confirm a reduced risk for either 
total dietary folate or supplemental folic acid vitamers 
 [91] .
 The existing data about a correlation between specific 
diets or their components and the risk of pancreatic can-
cer remains rather inconclusive and conflicting. Even if 
certain diets were to increase or decrease the risk of de-
veloping pancreatic cancer, their impact is marginal at 
best and well-founded recommendations cannot be made 
at this point. Advice beyond: don’t be overweight, eat a 
well-balanced diet, drink alcohol only with moderation 
and do not smoke – ever – would be premature as far as 
either chronic pancreatitis or pancreatic cancer is con-
cerned.
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